FSSAI Orders Removal of ‘ORS’ from Food and Beverage Labels

New Delhi– The Food Safety and Standards Authority of India (FSSAI) has directed all food and beverage manufacturers to immediately remove the term “ORS” (Oral Rehydration Solution) from product labels, citing misleading claims about health benefits.

The order aims to prevent consumer confusion, as only medically certified ORS products can use the term. Non-compliance will attract fines up to ₹10 lakh. Manufacturers have 30 days to update packaging. FSSAI emphasized stricter enforcement to protect public health.

Background: Public Interest Litigation

The regulatory intervention follows a nearly decade-long campaign by Hyderabad-based paediatrician Dr. Sivaranjani Santosh against sugar-rich beverages falsely marketed as ORS. In 2022, she filed a Public Interest Litigation (PIL) in the Telangana High Court challenging beverages that claimed to be ORS but failed to meet WHO-recommended electrolyte and glucose standards.

Her petition highlighted the potential health risks, especially to children and diabetic patients, and her complaints reached the Ministry of Health and Family Welfare, prompting regulatory scrutiny.

Court and Regulatory Actions

The Telangana High Court directed FSSAI and the Drug Controller General of India to respond, recognising the public health implications of misleading ORS claims.

In April 2022, FSSAI issued its first restriction, but in July the regulator temporarily allowed companies holding valid trademarks to continue production until the Controller General of Patents, Designs and Trademarks issued a final decision.

Health Risks from Mislabelled Beverages

WHO-approved ORS has a total osmolarity of 245 mOsm/L, with precise quantities of sodium, potassium, chloride, and dextrose. In contrast, many marketed products contained up to 120 grams of sugar per litre, with minimal electrolytes, posing serious health risks.

Related Posts

Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

New Delhi — A relentless surge in seizures of codeine-based cough syrups and narcotic tablets across multiple states over the past 48-72 hours has laid bare the rampant diversion of…

Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

Pune— In a major breakthrough exposing vulnerabilities in India’s pharmaceutical supply chain, the Food and Drug Administration (FDA) Pune Division has declared batches of “RituxiRel” (a counterfeit version of Rituximab,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

TN, Karnataka, Rajasthan declare highest number of NSQs in January

TN, Karnataka, Rajasthan declare highest number of NSQs in January

Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

CDSCO modifies norms for testing permissions to speed up drug approvals

CDSCO modifies norms for testing permissions to speed up drug approvals

British men jailed for smuggling cocaine into Bali

British men jailed for smuggling cocaine into Bali